RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Project Detail
Is the mTOR pathway relevant in the initiation/progression and/or a putative therapeutic target in melanomas?
 
Team
José Manuel Lopes (PI), Paula Soares (PI), João Vinagre
 
Sponsor
Novartis Farma
 
Dates and Lifetime
From: 2006-07-01 To: 2008-06-10
 
Reference
  
 
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject